High Quality Integrated Drug R&D
One stop for all your preclinical R&D needs
A Comprehensive CRO for Pre-Clinical Pharmaceutical R&D
End-to-end services and solutions covering the entire spectrum of preclinical biopharmaceutical R&D. Supporting everything from target discovery, candidate development, preclinical screening and drug safety evaluation through IND submission. Focus on communication and collaboration with clients in a variety of target indication areas such as neoplasms, neurological diseases, diabetes, inflammation, etc
State-of-the-Art Facilities
- Three R&D centers with 910,000+ square feet of lab space in Shanghai, China
- AAALAC accredited animal facilities
- GLP/GMP compliant facilities and instrumentation operated in accordance with both FDA and NMPA regulations
High-Performance Teams
- 3,000+ scientists and service personnel
- Led by internationally trained scientists with Ph.D. degree and/or with 10+ years of R&D and management experience
- Provide timely support and consultations through one-on-one communication
IP Protection
- Strict adherence to rigorous internal policies and an excellent historical track record